Literature DB >> 2166581

DNA topoisomerase I from human placenta.

J A Holden1, D H Rolfson, R L Low.   

Abstract

In this study we report that human placenta is an excellent source of DNA topoisomerase I. The enzyme can be isolated in the fully intact 100 kDa form although lower molecular mass species are also observed. Occasionally, the enzyme can be resolved into two peaks of activity by chromatography on phosphocellulose. As expected, the enzyme promotes marked cleavage of DNA in response to the anticancer drug camptothecin. Because of this property and the ready availability of human placenta, the enzyme should prove to be useful in the development and testing of new anticancer drugs that target topoisomerase I.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166581     DOI: 10.1016/0167-4781(90)90102-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

1.  Deoxyamphimedine, a pyridoacridine alkaloid, damages DNA via the production of reactive oxygen species.

Authors:  Kathryn M Marshall; Cynthia D Andjelic; Deniz Tasdemir; Gisela P Concepción; Chris M Ireland; Louis R Barrows
Journal:  Mar Drugs       Date:  2009-05-25       Impact factor: 5.118

2.  Effect of CPT on the calf thymus Topoisomerase I-mediated DNA breakage-reunion reaction: optimal conditions for the formation and reversal of the CPT trapped Topoisomerase I cleavable complex.

Authors:  S Coderoni; M Paparelli; G L Gianfranceschi
Journal:  Mol Biol Rep       Date:  1993-02       Impact factor: 2.316

3.  Specific regulatory role of phosphorylation of calf thymus DNA-topoisomerase I smaller forms on the relaxational activity expression. Phosphorylation role on Topo I smaller forms activity.

Authors:  S Coderoni; M Paparelli; G L Gianfranceschi
Journal:  Mol Biol Rep       Date:  1992-05       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.